FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称2-AMINO-N-(8-(3-(FORMYL(2-HYDROXYETHYL)AMINO)PROPOXY)-2,3-DIHYDRO-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-5-PYRIMIDINECARBOXAMIDE
异名/同义词2-AMINO-N-(8-(3-(FORMYL(2-HYDROXYETHYL)AMINO)PROPOXY)-2,3-DIHYDRO-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-5-PYRIMIDINECARBOXAMIDE
5-PYRIMIDINECARBOXAMIDE, 2-AMINO-N-(8-(3-(FORMYL(2-HYDROXYETHYL)AMINO)PROPOXY)-2,3-DIHYDRO-7-METHOXYIMIDAZO(1,2-C)QUINAZOLIN-5-YL)-
COPANLISIB METABOLITE M21
CAS登记号2132943-82-7
物质唯一标识(Unique Ingredient Identifier)RTW1LKQ7TC
分子式C22H26N8O5
国际化合物标识(International Chemical Identifier,InChI)GBAWZLUDIKNBLK-UHFFFAOYSA-N
SMILESCOc1c(ccc2c1N=C(N3C2=NCC3)NC(=O)c4cnc(nc4)N)OCCCN(CCO)C=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
    扩展资源
    ©2006-2025 Drugfuture->FDA Global Substance Registration System